Impact Biomedical Inc (IBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 3 | 1,999 | 1 | 2 |
| Receivables | 5 | N/A | 128 | N/A |
| Inventories | 63 | 0 | N/A | N/A |
| Other current assets | 198 | 184 | 203 | 16 |
| TOTAL | $411 | $2,448 | $332 | $122 |
| Non-Current Assets | ||||
| PPE Net | 0 | 17 | 287 | 276 |
| Investments And Advances | 0 | 0 | 0 | 782 |
| Intangibles | 16,994 | 17,808 | 44,014 | 45,127 |
| Other Non-Current Assets | 0 | 17 | 0 | 190 |
| TOTAL | $16,994 | $17,842 | $44,301 | $46,375 |
| Total Assets | $17,405 | $20,290 | $44,633 | $46,497 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 968 | 713 | 832 | 539 |
| Accrued Expenses | 194 | 194 | 230 | 63 |
| TOTAL | $1,162 | $9,785 | $13,136 | $10,593 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 32 | 62 | 71 | 204 |
| TOTAL | $688 | $3,268 | $3,235 | $3,235 |
| Total Liabilities | $1,850 | $13,053 | $16,371 | $13,828 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 107,821 | 12,085 | 10,000 | N/A |
| Common Shares | 105 | 11 | 10 | 70 |
| Retained earnings | -49,507 | -37,669 | -12,961 | -8,625 |
| Other shareholders' equity | 2,946 | 2,978 | 3,040 | 3,111 |
| TOTAL | $15,555 | $7,237 | $28,262 | $32,669 |
| Total Liabilities And Equity | $17,405 | $20,290 | $44,633 | $46,497 |